Currently out of the existing stock ratings of Trung Huynh, 25 are a HOLD (43.1%), 31 are a BUY (53.45%), 2 are a SELL (3.45%).

Trung Huynh

Work Performance Price Targets & Ratings Chart

Analyst Trung Huynh, currently employed at UBS, carries an average stock price target met ratio of 60.55% that have a potential upside of 9.69% achieved within 166 days. Previously, Trung Huynh worked at CREDIT SUISSE.

Trung Huynh’s has documented 114 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 10-Nov-2025.

Wall Street Analyst Trung Huynh

Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 4/28/2023. The price target of $420 was fulfilled within 5 days with a profit of $31.61 (8.14%) receiving and performance score of 16.28.

Average potential price target upside

of $80.68 (13.47%) on LLY (ELI LILLY AND COMPANY).
of $39.23 (6.68%) on REGN (REGENERON PHARMACEUTICALS).
of $33.57 (11.67%) on AMGN (AMGEN).

GRFS Grifols SA ADR BMY Bristol-Myers Squibb Company AMGN Amgen MRK Merck mpany JNJ Johnson & Johnson LLY Eli Lilly and Company LBTSF Almirall PFE Pfizer RHHBY Roche Holding Ltd ADR AZN AstraZeneca PLC ADR ABBV AbbVie INSM Insmed REGN Regeneron Pharmaceuticals CABA Cabaletta Bio GMAB Genmab AS JSPR Jasper Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

James Gordon (JPMORGAN)